Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v2.4.0.6
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Mar. 31, 2012
Current assets:    
Cash and cash equivalents $ 7,191 $ 7,820
Prepaid expenses and other current assets 19 56
Other assets of discontinued operations 11 418
Total current assets 7,221 8,294
Property and equipment, net 53 56
Note receivable - CollabRx 300 0
Investment in convertible promissory note 320 312
Total assets 7,894 8,662
Current liabilities:    
Accounts payable 15 1
Common stock warrant liability 18 19
Accrued expenses and other current liabilities 200 316
Liabilities of discontinued operations 206 246
Total current liabilities 439 582
Stockholders' equity:    
Preferred stock, $0.01 par value; 5,000,000 shares authorized; none issued and outstanding 0 0
Common stock, $0.01 par value; 50,000,000 shares authorized; 1,688,807 and 1,688,807 shares issued and outstanding at June 30, 2012 and March 31, 2012, respectively 17 17
Additional paid-in capital 129,106 129,052
Accumulated other comprehensive loss (142) (142)
Accumulated deficit (121,526) (120,847)
Total stockholders' equity 7,455 8,080
Total liabilities and stockholders' equity $ 7,894 $ 8,662